The Vmn1r124 Inhibitors are primarily focused on chemicals that can influence the signaling pathways and cellular processes associated with the vomeronasal 1 receptor 124. This receptor, part of the vomeronasal system, is crucial for detecting pheromones and triggering appropriate physiological responses. The inhibitors or modulators listed are not direct antagonists of Vmn1r124 but rather influence the receptor's functionality by altering the cellular environment or the signaling cascades in which it participates. The first aspect to consider is the impact of these chemicals on cellular signaling pathways. Compounds like PD 98059, LY294002, U73122, SB 203580, and Wortmannin play significant roles in modulating key signaling molecules such as MEK, PI3K, phospholipase C, p38 MAP kinase, and mTOR. These pathways are crucial in various cellular processes, including cell proliferation, survival, and differentiation. By inhibiting these pathways, the chemicals indirectly influence the cellular context in which Vmn1r124 operates, potentially modulating the receptor's ability to respond to stimuli or affecting its expression levels.
Another aspect is the effect of these inhibitors on cellular transport and enzymatic activities that are indirectly associated with Vmn1r124 functioning. Brefeldin A, for example, disrupts protein transport, which could affect the receptor's trafficking to the membrane, a critical step for its functionality. Similarly, inhibitors like KN-93 Phosphate, ML-7 Hydrochloride, and Genistein target specific enzymes like Ca2+/calmodulin-dependent protein kinase II, myosin light chain kinase, and tyrosine kinases, respectively. These enzymes are part of broader cellular processes that could impact the receptor's environment or signaling ability. In summary, Vmn1r124 Inhibitors encompass a range of chemicals that target various aspects of cellular functioning, from signaling pathways to enzymatic activities, thereby providing indirect means to modulate the vomeronasal 1 receptor 124. These inhibitors offer insight into potential methods of influencing the receptor's activity, emphasizing the complex interplay of cellular components and signaling networks in determining receptor functionality.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Inhibits protein transport in eukaryotic cells, potentially affecting Vmn1r124 trafficking to the membrane. | ||||||
W-7 | 61714-27-0 | sc-201501 sc-201501A sc-201501B | 50 mg 100 mg 1 g | $166.00 $306.00 $1675.00 | 18 | |
Calmodulin antagonist, may indirectly influence Vmn1r124 signaling pathways that involve calmodulin. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
Inhibits Ca2+/calmodulin-dependent protein kinase II, possibly affecting Vmn1r124 associated pathways. | ||||||
ML-7 hydrochloride | 110448-33-4 | sc-200557 sc-200557A | 10 mg 50 mg | $91.00 $267.00 | 13 | |
Inhibits myosin light chain kinase, potentially impacting cellular processes linked with Vmn1r124. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Inhibits MEK, which could indirectly affect Vmn1r124 signaling through the MAPK pathway. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3K inhibitor, possibly influencing Vmn1r124-related signaling via the PI3K/Akt pathway. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Inhibits p38 MAP kinase, potentially modulating Vmn1r124-related pathways. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Tyrosine kinase inhibitor, could indirectly affect Vmn1r124 through modulation of tyrosine kinase activity. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Inhibits PI3K, potentially influencing pathways associated with Vmn1r124. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Inhibits mTOR, which could have downstream effects on Vmn1r124 signaling. | ||||||